Clinical Trial Update: Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on anidulafungin for invasive candidiasis in children has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Invasive Candidiasis

Drugs mentioned

• Anidulafungin (anidulafungin)

Snippet

Sponsor: Pfizer | Conditions: Candidemia | Phase 3 | Status: COMPLETED | Results posted: 2018-09-14